Fatty Liver Disease (FLD) is a systemic disorder with far-reaching consequences beyond the liver. It disrupts hepatic functions through oxidative stress, inflammation, and insulin resistance, leading to increased risk of cardiovascular disease, type 2 diabetes, and chronic kidney disease. While simple steatosis has a benign course, more severe forms, such as NASH, can progress to cirrhosis and liver cancer.
Gallstones are more common in people with fatty liver, and the two share risk factors such as obesity, insulin resistance and diabetes. How bile composition and gallbladder emptying link them, and what research on choline, inositol, methionine and taurine has and has not shown.
Research links a leaky gut with fatty liver: bacterial products cross a weakened gut barrier, reach the liver through the portal vein and can trigger inflammation. Whether this is a cause or a consequence of fatty liver in people is still unclear.
Lower thyroid function is linked with more fat in the liver, though studies show an association rather than proof of cause. How Hashimoto’s affects lipid metabolism and what is known about choline, inositol, methionine and taurine.
Liver fat behaves very differently from fat under the skin. A healthy liver already holds 2–5% fat, so even a small rise can cross the threshold for steatosis. How much matters, what it drives, and why nutrients such as choline are an addition to diet changes, not a replacement.
Leave your name and phone. We'll call you during working hours: Monday–Friday, 9:00–19:00.
